John P. O’Rourke

4.6k total citations · 1 hit paper
34 papers, 3.8k citations indexed

About

John P. O’Rourke is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, John P. O’Rourke has authored 34 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 7 papers in Immunology and 6 papers in Genetics. Recurrent topics in John P. O’Rourke's work include Virus-based gene therapy research (6 papers), T-cell and Retrovirus Studies (4 papers) and CRISPR and Genetic Engineering (4 papers). John P. O’Rourke is often cited by papers focused on Virus-based gene therapy research (6 papers), T-cell and Retrovirus Studies (4 papers) and CRISPR and Genetic Engineering (4 papers). John P. O’Rourke collaborates with scholars based in United States, United Kingdom and Spain. John P. O’Rourke's co-authors include Christopher J. Schofield, Norma Masson, Michael Wilson, Eric Metzen, Donald L. Hamilton, Jonathan Hodgkin, Christopher W. Pugh, Ya‐Min Tian, Jonathan Gleadle and Mridul Mukherji and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

John P. O’Rourke

34 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

C. elegans EGL-9 and Mammalian Homologs Define a Family of Dioxygenases that Regulate HIF by Prolyl Hydroxylation

2001 2.7k citations Andrew Epstein, Jonathan Gleadle et al. Cell profile →

Peers

Countries citing papers authored by John P. O’Rourke

Since Specialization

Citations

This map shows the geographic impact of John P. O’Rourke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John P. O’Rourke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John P. O’Rourke more than expected).

Fields of papers citing papers by John P. O’Rourke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John P. O’Rourke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John P. O’Rourke. The network helps show where John P. O’Rourke may publish in the future.

Co-authorship network of co-authors of John P. O’Rourke

This figure shows the co-authorship network connecting the top 25 collaborators of John P. O’Rourke. A scholar is included among the top collaborators of John P. O’Rourke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John P. O’Rourke. John P. O’Rourke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	TLR Agonist Nano Immune Therapy Clears Peritoneal and Systemic Ovarian Cancer 2024 ·Advanced Healthcare Materials ·(unknown), (unknown), (unknown), (unknown), Erin B. Kennedy, (unknown), John P. O’Rourke, Marian Olewine, Irina V. Lagutina, (unknown), (unknown), Donna F. Kusewitt, Eric Bartee, Sarah Adams, Achraf Noureddine, Rita E. Serda	2
2	Affinity selection of epitope-based vaccines using a bacteriophage virus-like particle platform 2015 ·Current Opinion in Virology ·John P. O’Rourke, David S. Peabody, Bryce Chackerian	22
3	Development of a Mimotope Vaccine Targeting the Staphylococcus aureus Quorum Sensing Pathway 2014 ·PLoS ONE ·John P. O’Rourke, Seth M. Daly, Kathleen D. Triplett, David S. Peabody, Bryce Chackerian, Pamela R. Hall	23
4	Early dynamic fate changes in haemogenic endothelium characterized at the single-cell level 2013 ·Nature Communications ·Gemma Swiers, Claudia Baumann, John P. O’Rourke, Eleni Giannoulatou, Stephen Taylor, Anagha Joshi, Victoria Moignard, Cristina Pina, Thomas Bee, Konstantinos D. Kokkaliaris, Momoko Yoshimoto, Mervin C. Yöder, Jon Frampton, Timm Schroeder, Tariq Enver, Berthold Göttgens, Marella de Bruijn	145
5	Dlk1 is a negative regulator of emerging hematopoietic stem and progenitor cells 2012 ·Haematologica ·Bahar Mirshekar-Syahkal, Esther Haak, (unknown), (unknown), Kevin Harvey, John P. O’Rourke, Jorge Laborda, Steven R. Bauer, Marella de Bruijn, Anne C. Ferguson‐Smith, Elaine Dzierzak, Katrin Ottersbach	41
6	Identification and Regulation of c-Myb Target Genes in MCF-7 Cells 2011 ·BMC Cancer ·Anita M. Quintana, Fan Liu, John P. O’Rourke, Scott A. Ness	76
7	Dramatic Repositioning of c-Myb to Different Promoters during the Cell Cycle Observed by Combining Cell Sorting with Chromatin Immunoprecipitation 2011 ·PLoS ONE ·Anita M. Quintana, (unknown), (unknown), John P. O’Rourke, Scott A. Ness	22
8	Single Molecule Analysis of c-myb Alternative Splicing Reveals Novel Classifiers for Precursor B-ALL 2011 ·PLoS ONE ·(unknown), John P. O’Rourke, Jeremy S. Edwards, Scott A. Ness	15
9	Expression levels of the human DNA repair protein metnase influence lentiviral genomic integration 2008 ·Biochimie ·Elizabeth A. Williamson, (unknown), (unknown), Scott A. Ness, John P. O’Rourke, Suk‐Hee Lee, Jac A. Nickoloff, Robert Hromas	17
10	Oncogenic mutations cause dramatic, qualitative changes in the transcriptional activity of c-Myb 2005 ·Oncogene ·(unknown), Wenliang Lei, John P. O’Rourke, Scott A. Ness	35
11	Optimization of equine infectious anemia derived vectors for hematopoietic cell lineage gene transfer 2004 ·Gene Therapy ·John P. O’Rourke, John C. Olsen, Bruce A. Bunnell	12
12	Analysis of gene transfer and expression in skeletal muscle using enhanced EIAV lentivirus vectors 2003 ·Molecular Therapy ·John P. O’Rourke, Hajime Hiraragi, (unknown), (unknown), John C. Olsen, Bruce A. Bunnell	29
13	C. elegans EGL-9 and Mammalian Homologs Define a Family of Dioxygenases that Regulate HIF by Prolyl Hydroxylation breakdown → 2001 ·Cell ·Andrew Epstein, Jonathan Gleadle, Luke A. McNeill, Kirsty S. Hewitson, John P. O’Rourke, David R. Mole, Mridul Mukherji, Eric Metzen, Michael Wilson, (unknown), Ya‐Min Tian, Norma Masson, Donald L. Hamilton, Panu Jaakkola, Robert Barstead, Jonathan Hodgkin, Patrick H. Maxwell, Christopher W. Pugh, Christopher J. Schofield, Peter J. Ratcliffe	2746
14	Rhesus Monkey Model for Fetal Gene Transfer: Studies with Retroviral- Based Vector Systems 2001 ·Molecular Therapy ·Alice F. Tarantal, John P. O’Rourke, Scott S. Case, Garret C. Newbound, Jun Li, C. Lee, Carole R. Baskin, Donald B. Kohn, Bruce A. Bunnell	54
15	Repression of tax‐mediated human t‐lymphotropic virus type 1 transcription by inducible cAMP early repressor (ICER) protein in peripheral blood mononuclear Cells 2000 ·Journal of Medical Virology ·Garret C. Newbound, John P. O’Rourke, Nathaniel D. Collins, (unknown), James W. DeWille, Michael D. Lairmore	2
16	Signal Transducer and Activator of Transcription 3 Activates CCAAT Enhancer-binding Protein δ Gene Transcription in G0Growth-arrested Mouse Mammary Epithelial Cells and in Involuting Mouse Mammary Gland 2000 ·Journal of Biological Chemistry ·Julie A. Hutt, John P. O’Rourke, (unknown)	70
17	Transcriptional Regulation of C/EBPδ in G0 Growth-Arrested Mouse Mammary Epithelial Cells 1999 ·Biochemical and Biophysical Research Communications ·John P. O’Rourke, Julie A. Hutt, (unknown)	27
18	CCAAT/Enhancer-binding Protein δ Regulates Mammary Epithelial Cell G0 Growth Arrest and Apoptosis 1999 ·Journal of Biological Chemistry ·John P. O’Rourke, Garret C. Newbound, Julie A. Hutt, (unknown)	66
19	Comparison of HTLV-I Basal Transcription and Expression of CREB/ATF-1/CREM Family Members in Peripheral Blood Mononuclear Cells and Jurkat T Cells 1999 ·Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology ·Garret C. Newbound, John P. O’Rourke, Nathaniel D. Collins, James W. DeWille, Michael D. Lairmore	7
20	Effect of Transforming Growth Factor-β1 on Parathyroid Hormone-Related Protein Secretion and mRNA Expression by Normal Human Keratinocytes In Vitro 1998 ·Endocrine ·(unknown), Eric A.G. Blomme, Michelle T. Weckmann, Andrea Gröne, (unknown), (unknown), John P. O’Rourke, C. C. Capen, Thomas J. Rosol	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact